Filing Details
- Accession Number:
- 0000905718-17-000829
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-11 09:00:29
- Reporting Period:
- 2017-09-08
- Accepted Time:
- 2017-09-11 09:00:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1582554 | Matinas Biopharma Holdings Inc. | MTNB | Pharmaceutical Preparations (2834) | 463011414 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1698966 | Roelof Rongen | C/O Matinas Biopharma Holdings, Inc. 1545 Route 206 South, Suite 302 Bedminster NJ 07921 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-09-08 | 5,000 | $1.36 | 3,539,416 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
